NCT01774942

Brief Summary

Gum disease and type 2 diabetes are common chronic diseases that affect each other. Diabetes is increasing, especially in Pakistan. People with diabetes have a greater risk for gum disease. Also, it is thought that that gum disease, a chronic infection, can be a source of systemic inflammation and may contribute to poorer diabetes control. The aims of this project are to study:

  1. 1.Changes in sugar control in people with type 2 diabetes and severe gum disease after having all teeth removed and replaced with Straumann dental implants and full dentures
  2. 2.Changes in certain inflammation markers seen with insulin resistance and other diseases and conditions more common in people with diabetes
  3. 3.Retention of dental implants in people with type 2 diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
4.6 years until next milestone

First Submitted

Initial submission to the registry

January 21, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 24, 2013

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2015

Completed
Last Updated

November 15, 2018

Status Verified

November 1, 2018

Enrollment Period

7.2 years

First QC Date

January 21, 2013

Last Update Submit

November 13, 2018

Conditions

Keywords

Diabetes MellitusC-Reactive ProteinDental Implants, Single-ToothDental Prosthesis, Implant-Supported

Outcome Measures

Primary Outcomes (1)

  • Glycosylated hemoglobin (HbA1a)

    Level measured every 3 months during the first year after implant placement; then every 6 months the following 5 years, for a total of 6 years.

    Every 3 months/6 months

Secondary Outcomes (1)

  • high-sensitivity C-reactive protein (hsCRP)

    Every 3 months/6 months

Other Outcomes (1)

  • Retention of implants

    6 years

Study Arms (1)

Procedure/Surgery (Impants/Overdentures)

EXPERIMENTAL

One-arm clinical intervention study: All teeth out, full dentures, dental implants, blood draw. The interventions are not experimental in nature, they are standard procedures, namely extraction of all natural teeth followed by suturing to hold soft tissue in place during initial healing; surgical insertion of commercially available dental implants; and fabrication and re-lining (filling in with acrylic the base of the denture as needed during healing and shrinking of underlying tissue) of full dentures, that is full plates in upper and lower jaw to replace all teeth.

Procedure: Procedure/Surgery

Interventions

All teeth were extracted and replaced by a set of provisional full dentures in upper and lower jaws. Three months after extractions, dental implants were surgically placed and mucosa sutured over them. Three monts later, the dentures were re-lined and fitted onto the implants. Blood draw done by phlebotomist.

Also known as: All teeth out, full dentures, dental implants, blood draw
Procedure/Surgery (Impants/Overdentures)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • type 2 diabetes of at least 6 months duration and uncontrolled (HbA1c at least 7.5%)
  • all teeth in dentition in need of extraction due to periodontal (gum) disease (end-stage or terminal periodontitis)
  • able to return for examination every three months for the first year after implant placement, then every 6 months for five years after implant placement
  • willing to have blood drawn at each follow-up visit

You may not qualify if:

  • ≤ 6 natural teeth
  • inflammatory conditions/diseases other than type 2 diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rahman & Rahman Dental Surgeons

Lahore, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

InflammationDiabetes Mellitus

Interventions

Surgical Procedures, OperativeDental ImplantsBlood Specimen Collection

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Dental MaterialsBiomedical and Dental MaterialsDental ProsthesisProsthodonticsDentistryProstheses and ImplantsEquipment and SuppliesManufactured MaterialsTechnology, Industry, and AgricultureSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesInvestigative Techniques

Study Officials

  • Wenche S Borgnakke, DDS MPH PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR
  • Amin ur Rahman, BDS MPH Cert

    Rahman & Rahman Dental Surgeons, Lahore, Pakistan

    STUDY DIRECTOR
  • William V Giannobile, DDS MS DMSc

    University of Michigan

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Because it is unethical to withhold treatment that is known to be efficacious for severe periodontal infections, there is no control group that would not be treated or that would receive delayed treatment. Enrollment criteria included end-stage ("terminal") periodontal infection of all teeth, which is a condition that must be treated immediately due to its severity and potential for very severe consequences.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Clinical Assistant Professor

Study Record Dates

First Submitted

January 21, 2013

First Posted

January 24, 2013

Study Start

June 1, 2008

Primary Completion

August 28, 2015

Study Completion

August 28, 2015

Last Updated

November 15, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share

Locations